Last Updated: Monday, September 16, 2013, 19:37
Pharmaceutical entity Zydus group today said it has launched Lipaglyn, its patented new drug for treatment of diabetes.
Last Updated: Wednesday, June 05, 2013, 16:09
Cadila Healthcare today said Indian drug regulator has approved its new chemical entity, Lipaglyn to be used for treating a type of diabetes for launch in the country.
Last Updated: Friday, May 17, 2013, 00:26
Drug firm Zydus Cadila today said it has launched Zolmitriptan orally disintegrating tablets, a migraine drug, in the American market after getting approval from the US health regulator.
Last Updated: Wednesday, August 01, 2012, 00:39
Drug firm Zydus Cadila today said it has received the US health regulator`s approval to market aripiprazole orally disintegrating tablets, used in treating schizophrenia, in the American market.
Last Updated: Friday, April 27, 2012, 19:04
Drugmakers are looking to recover some of their investments amid a new outbreak of the deadly virus in India.
Last Updated: Wednesday, January 06, 2010, 00:00
A new H1N1 vaccine may hit medical
stores by April and clinical trials have already begun, its
makers today said.
Last Updated: Saturday, October 31, 2009, 00:00
Cadila Pharmaceuticals Ltd, a Gujarat-based pharma company, on Saturday launched Risorine, the first indigenously prepared drug for treatment of tuberculosis in the country.
Last Updated: Tuesday, August 11, 2009, 00:00
With an aim to launch vaccine for
Influenza H1N1 A Virus (swine flu) in India, Cadila
Pharmaceutical will seek the government`s nod in two days for
initiating clinical trials in this regard.